Marvin & Palmer Associates’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.85M Buy
30,136
+3,196
+12% +$399K 4.61% 4
2025
Q4
$3.28M Buy
+26,940
New +$3.09M 2.32% 22
2024
Q4
Sell
-76,769
Closed -$7.58M 42
2024
Q3
$7.58M Buy
+76,769
New +$7.54M 6.36% 2
2018
Q4
Sell
-74,728
Closed -$7.16M 34
2018
Q3
$7.16M Buy
74,728
+20,246
+37% +$1.96M 5.43% 4
2018
Q2
$5.19M Hold
54,482
5.1% 6
2018
Q1
$4.78M Buy
54,482
+39,972
+275% +$3.65M 4.38% 8
2017
Q4
$1.23M Hold
14,510
1.28% 29
2017
Q3
$1.26M Buy
+14,510
New +$1.16M 1.54% 25

Other funds holding XBI